Clinical Trial Update: Folic Acid Dosage and Malformations Reduction [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating folic acid dosage and its potential to reduce congenital malformations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Malformations

Drugs mentioned

• folic acid (folic acid)

Snippet

Sponsor: Azienda Ospedaliera Universitaria Integrata Verona | Conditions: Congenital Malformations | Phase 3 | Status: UNKNOWN